Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
基本信息
- 批准号:10202909
- 负责人:
- 金额:$ 49.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAgeAgingAngiogenic FactorAnimalsAortaAttenuatedBloodBlood CirculationBlood VesselsBlood capillariesBone DensityBone MarrowBone Marrow TransplantationBrainCDKN2A geneCardiovascular DiseasesCardiovascular systemCell AgingCell LineageCellsCerebrovascular DisordersCerebrovascular systemCerebrumClinicalClinical ResearchCross-Sectional StudiesDataDementiaDevelopmentDistalElderlyEndocrine GlandsEventExposure toGeneticGoalsHealthHomeostasisHormonalImageImpairmentIncidenceInfusion proceduresKnockout MiceLeadLinkLongitudinal StudiesMacrophage Colony-Stimulating FactorMediatingMononuclearMorbidity - disease rateMusNeurodegenerative DisordersOrganOsteoclastsOsteoporosisParabiosisPathologicPatientsPeripheralPhenotypePhysiologicalPhysiologyPlasmaPopulationPositioning AttributeReporterRisk FactorsRoleSerumSkeletonSourceStructureTNFSF11 geneTechniquesTestingTissuesTransgenic MiceVascular SystemWhite Matter DiseaseWorkagedarterial stiffnessbonebone agebone metabolismcalcificationcell typecerebral capillarycerebrovascularcerebrovascular pathologycognitive changeconditional knockoutdefined contributiondensitydisabilityexperimental studyhuman subjectmacrophagemonocytemortalitymouse modelnovelplatelet-derived growth factor BBpublic health relevanceresponsesenescenceskeletal
项目摘要
ABSTRACT/SUMMARY
Cardiovascular and cerebrovascular diseases are the leading causes of mortality and disability, especially in the
elderly population. Accumulating evidence suggest that circulating pro-aging factors derived from distal organs
exacerbate the aging of vascular system. Particularly, there is a link between bone metabolism and the
vasculature. Clinical studies have shown an inverse, independent correlation between osteoporosis and vascular
events, such as aortic stiffening and cerebrovascular disease. Therefore, the bone-vascular interplay likely
involves mechanisms underlying the aging of cardiovascular and cerebrovascular system. Our goal is to identify
skeleton-derived factors that accelerate vascular aging through blood circulation. We recently found that old
animals have elevated serum level of angiogenesis factor PDGF-BB and develop increased aortic stiffness and
reduced density and integrity of brain capillaries relative to young mice. Importantly, acute infusion of aged
plasma into young mice induces an elevation in serum PDGF-BB concentration and a similar cerebrovascular
phenotype as seen in aged mice. We previously found that pre-osteoclasts (Pre-OCs) in bone/bone marrow is a
major cell type that secret PDGF-BB. Our preliminary data show that Pre-OCs undergo cellular senescence and
secrete high amount of PDGF-BB during aging. Our results suggest that Pre-OCs in bone/bone marrow is a
main source of elevated circulating PDGF-BB during aging. While PDGF-BB maintains the homeostasis of
vasculature under physiological conditions, abnormally high concentration of PDGF-BB may lead to vascular
impairment. Our central hypothesis is that skeleton-derived PDGF-BB is a systemic pro-aging factor to
exacerbate arterial stiffening and cerebrovascular dysfunction. In Aim 1, we will establish the role of PDGF-BB
as a systemic factor to exacerbate vascular aging by conducting plasma transfer and heterochonic parabiosis
studies to examine whether young mice develop age-associated aortic and cerebrovascular phenotype by
exposure to the blood of aged mice or Pdgfb transgenic mice. In Aim 2, we will define the contribution of
senescent Pre-OCs to vascular aging by conducting bone marrow transplantation experiments. We will also test
if ablation of Pre-OCs or inhibition of the senescence of Pre-OCs rescues the aortic and cerebrovascular
pathologies in aged mice. Positive findings will uncover the mechanisms by which skeletal cells regulate vascular
aging and will provide an unconventional but promising path for the treatment of cardiovascular and
cerebrovascular diseases.
抽象/总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mei Wan其他文献
Mei Wan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mei Wan', 18)}}的其他基金
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10090198 - 财政年份:2021
- 资助金额:
$ 49.12万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10544756 - 财政年份:2021
- 资助金额:
$ 49.12万 - 项目类别:
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10326804 - 财政年份:2021
- 资助金额:
$ 49.12万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10380873 - 财政年份:2021
- 资助金额:
$ 49.12万 - 项目类别:
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10556420 - 财政年份:2021
- 资助金额:
$ 49.12万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10417206 - 财政年份:2020
- 资助金额:
$ 49.12万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10634546 - 财政年份:2020
- 资助金额:
$ 49.12万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10547815 - 财政年份:2020
- 资助金额:
$ 49.12万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10326837 - 财政年份:2020
- 资助金额:
$ 49.12万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10041954 - 财政年份:2020
- 资助金额:
$ 49.12万 - 项目类别:
相似海外基金
Understanding age at first autism health claim and acute health service use in girls and women relative to boys and men
了解女孩和女性相对于男孩和男性的首次自闭症健康声明和紧急医疗服务使用情况
- 批准号:
419977 - 财政年份:2020
- 资助金额:
$ 49.12万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 49.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Proposal of a model plan for a high-activity operating department in an acute care hospital based on long-term PDCA in the age of minimally invasive treatment
微创治疗时代基于长期PDCA的急症医院高活动手术科室模型方案提出
- 批准号:
18K04486 - 财政年份:2018
- 资助金额:
$ 49.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ISCHAEMIC ACUTE RENAL FAILURE AND AGE: MODULATION BY ANTI-INFLAMMATORY EMBRYONIC STEM CELL-DERIVED MACROPHAGES
缺血性急性肾衰竭和年龄:抗炎胚胎干细胞源性巨噬细胞的调节
- 批准号:
G0801235/1 - 财政年份:2009
- 资助金额:
$ 49.12万 - 项目类别:
Research Grant
AGE-RELATED DIFFERENCES IN ENERGY EXPENDITURE IN RESPONSE TO ACUTE EXERCISE
剧烈运动时的能量消耗与年龄相关的差异
- 批准号:
7951393 - 财政年份:2009
- 资助金额:
$ 49.12万 - 项目类别:
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
- 批准号:
8306217 - 财政年份:2008
- 资助金额:
$ 49.12万 - 项目类别:
Age-related differences in the acute thermoregulatory responses to cold
对寒冷的急性体温调节反应与年龄相关的差异
- 批准号:
347633-2008 - 财政年份:2008
- 资助金额:
$ 49.12万 - 项目类别:
Postgraduate Scholarships - Master's
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
- 批准号:
7530462 - 财政年份:2008
- 资助金额:
$ 49.12万 - 项目类别:
Acute and chronic GPCR Medicated Cardioprotection: Roles of receptor Cross-Talk, Cellular signaling, and effects of Age
急性和慢性 GPCR 药物心脏保护:受体串扰的作用、细胞信号传导以及年龄的影响
- 批准号:
nhmrc : 428251 - 财政年份:2008
- 资助金额:
$ 49.12万 - 项目类别:
Career Development Fellowships
Age factors, mutations, and chemical suppressors of acute myelogenous leukemia
急性髓性白血病的年龄因素、突变和化学抑制剂
- 批准号:
8134266 - 财政年份:2008
- 资助金额:
$ 49.12万 - 项目类别:














{{item.name}}会员




